Skip to main content
SpringerLink
Log in

Elevated plasma prostaglandin E2 levels in schizophrenia

  • Original Papers
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

Plasma levels of prostaglandin E2 (PGE2) were determined with radioimmunoassay in 40 DSM-III schizophrenics, 15 patients with other mental disorders, and 23 normal controls. The mean value of plasma immunoreactivity of PGE2 was significantly higher in the schizophrenic patients than in the normal controls. Schizophrenic patients with high plasma PGE2 levels had more guilt feelings and hallucinatory behavior on BPRS, relatively successful heterosexual relations, and a higher incidence of birth complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abdulla YH, Hamadah K (1975) Effect of ADP on PGE1 formation in blood platelets from patients with depression, mania and schizophrenia. Br J Psychiatry 127: 591–595

    PubMed  Google Scholar 

  • Akaike H (1974) A new look at the statistical model identification. IEEE Trans Automat Contr AC-19: 716–723

    Google Scholar 

  • American Psychiatric Association (1980) DSM-III: diagnostic and statistical manual of mental disorders, 3rd edn. APA, Washington, DC

    Google Scholar 

  • Chiu EKY, Richardson JS (1985) Behavioral and neurochemical aspects of prostaglandins in brain function. Gen Pharmacol 16: 163–175

    PubMed  Google Scholar 

  • Davis JM (1976) Comparative doses and costs of antipsychotic medication. Arch Gen Psychiatry 33: 858–861

    PubMed  Google Scholar 

  • Feldberg W (1976) Possible association of scizophrenia with a disturbance in prostaglandin metabolism: a physiological hypothesis. Psychol Med 6: 359–369

    PubMed  Google Scholar 

  • Garver DL, Johnson C, Kanter DR (1982) Schizophrenia and reduced cyclic AMP production: evidence for the role of receptor-linked events. Life Sci 31: 1987–1992

    PubMed  Google Scholar 

  • Gerner RH, Merrill JE (1983) Cerebrospinal fluid prostaglandin E in depression, mania, and schizophrenia compared to normals. Biol Psychiatry 18: 565–569

    PubMed  Google Scholar 

  • Granstrom E, Fitzpatric FA, Kindahl H (1982) Radioimmunologic determination of 15-keto-13, 14-dihydro- PGE2: a method for its stable degradation product, 11-deoxy-15-keto-13, 14-dihydro-11 β, 16ξ-cyclo-PGE2. Methods Enzymol 86: 306–320

    PubMed  Google Scholar 

  • Horrobin DF (1977) Schizophrenia as a prostaglandin deficiency disease. Lancet i: 936–937

    Google Scholar 

  • Horrobin DF (1980) The regulation of prostaglandin biosynthesis: negative feedback mechanisms and the selective control of formation of 1 and 2 series prostaglandins: relevance to inflammation and immunity. Med Hypotheses 6: 687–709

    PubMed  Google Scholar 

  • Idaka E, Kaiya H, Horitsu H (1987) Determination of prostaglandin E2 in plasma of schizophrenics and healthy controls by gas chromatography-negative-ion chemical ionization mass spectrometry and radioimmunoassay. J Chromatogr Biomed Appl 420: 373–378

    Google Scholar 

  • Kafka MS, van Kammen DP, Bunney WE Jr (1979) Reduced cyclic AMP production in the blood platelets from schizophrenic patients. Am J Psychiatry 136: 685–687

    PubMed  Google Scholar 

  • Kafka MS, van Kammen DP (1983) α-Adrenergic receptor function in schizophrenia. Arch Gen Psychiatry 40: 264–270

    PubMed  Google Scholar 

  • Kafka MS, Kleinman JE, Karson CN, Wyatt RJ (1986) Alpha-adrenergic receptors and cyclic AMP production in a group of schizophrenic patients. Hillside J Clin Psychiatry 8: 15–24

    PubMed  Google Scholar 

  • Kaiya H, Imai H, Muramatsu Y, Nozaki M, Fujimura H, Adachi S, Namba M (1983) Platelet aggregation response in schizophrenia and prostaglandin E1. Psychiatry Res 9: 309–318

    PubMed  Google Scholar 

  • Kaiya H, Takeuchi K, Namba M, Imai A, Nakashima S, Nozawa Y (1984) Abnormal phosphatidylinositol—cycle of platelet membrane in schizophrenia—a preliminary study. Folia Psychiatry Neurol Jpn 38: 437–444

    Google Scholar 

  • Kaiya H, Takai A, Morita K (1985) Prostaglanden E1 treatment of schizophrenia: a second trial. In: Burrows GD, Norman TR, Dennerstein L (eds) Clinical and pharmacological studies in psychiatric disorders. J Libbey, London, pp 202–210

    Google Scholar 

  • Kaiya H, Takeda N, Takeuchi K, Morita K, Takai A, Adachi S, Imai A, Nakashima S, Nozawa Y (1986) Abnormal phosphatidylinositol (PI) -cycle in platelet membrane in schizophrenia. In: Shagass C, Josiassen RC, Bridger WH, Weiss KJ, Stoff D, Simpson GM (eds) Biological psychiatry 1985. Elsevier, New York (Developments in psychiatry, vol 7, pp 1160–1162)

    Google Scholar 

  • Kaiya H, Uematsu M, Yoshida H (1986) Biological subgrouping of schizophrenia: platelet aggregation response, prostaglandin E and MRI. Abstracts of the 15th CINP Congress, San Juan 1986, p 65

  • Kanof PD, Johns C, Davidson M, Siever LJ, Coccaro EF, Davis KL (1986) Prostaglandin receptor sensitivity in psychiatric disorders. Arch Gen Psychiatry 43: 987–993

    PubMed  Google Scholar 

  • Lee RE (1974) The influence of psychotropic drugs on prostaglandin biosynthesis. Prostaglandins 5: 63–68

    PubMed  Google Scholar 

  • Linnoila M, Whorton AR, Rubinow DR, Cowdry RW, Ninan PT, Waters RN (1983) CSF prostaglandin levels in depressed and schizophrenic patients. Arch Gen Psychiatry 40: 405–406

    PubMed  Google Scholar 

  • Mathé AA, Sedvall G, Wiesel FA, Nyback H (1980) Increased content of immunoreactive prostaglandin E in cerebrospinal fluid of patients with schizophrenia. Lancet i: 16–18

    Google Scholar 

  • Mathé AA, Apéria B, Bergman P, Eberhard G, Jerling M, Sääf J, Thoren M, Ullberg C, Undén F, Wahlund B, Wetterberg L (1986a) Prostaglandin in schizophrenia, major affective disorder and Cushing's disease. In: Shagass C, Josiassen RC, Bridger WH, Weiss KJ, Stoff D, Simpson GM (eds) Biological psychiatry 1985. Elsevier, New York (Developments in psychiatry. Vol. 7, pp 1172–1174)

    Google Scholar 

  • Mathé AA, Eberhard G, Sääf J, Wetterberg L (1986b) Plasma prostaglandin E2 metabolite—measured as 11-deoxy-15-keto-13, 14-dihydro-11 β. 16ξ-cyclo-PGE2—in twins with schizophrenic disorder. Biol Psychiatry 21: 1024–1030

    PubMed  Google Scholar 

  • Mathé AA, Apéria B, Bergman P, Eberhard G, Jerling M, Lindstrom L, Sääf J, Undén F, Wetterberg (1987) Metabolic products of arachidonic acid in the central nervous system: possible role in mental disorders. In: Samuelsson B, Paoletti R, Ramwell PW (eds) Advances in prostaglandin, thromboxane, leukotriene research, vol 17. Raven Press, New York, pp 958–962

    Google Scholar 

  • Ohishi K, Ueno R, Asaba H, Sakai T, Hayaishi O (1986) Determination of PGD2, PGE2, and PGF2α like immunoreactivities in saliva from psychiatric patients and normal controls. In: Shagass C, Josiassen RC, Bridger WH, Weiss KJ, Stoff D, Simpson GM (eds) Biological psychiatry 1985. Elsevier, New York (Developments in psychiatry, vol 7, pp 1169–1171)

    Google Scholar 

  • Oliw E, Granstrom E, Anggard E (1983) The prostaglandins and essential fatty acids. In: Pace-Asciak C, Granstrom E (eds) Prostaglandins and related substances. Elsevier, Amsterdam, pp 1–44

    Google Scholar 

  • Overall JE, Gorham DR (1962) The brief psychiatric rating scale. Psychol Rep 10: 799–812

    Google Scholar 

  • Rigas VA, van Vunakis H, Levine L (1981) The effect of phenothiazines and their metabolites on prostaglandin production by rat basophilic leukemia cells in culture. Prostaglandin Med 7: 183–193

    Google Scholar 

  • Rotrosen J, Miller AD, Mandio D, Traficante LJ, Gershon S (1980) Prostaglandins, platelets, and schizophrenia. Arch Gen Psychiatry 37: 1047–1054

    PubMed  Google Scholar 

  • Salmon JA, Karim SMM (1976) Methods for analysis of prostaglandins. In: Karim SMM (ed) Prostaglandins: chemical and biochemical aspects. MTP Press, Lancaster, pp 25–85

    Google Scholar 

  • Strauss JS, Carpenter WT (1974) The prediction of outcome in schizophrenia. II. Relationships between predictor and outcome variables: a report from WHO international Pilot Study of Schizophrenia. Arch Gen Psychiatry 31: 37–42

    PubMed  Google Scholar 

  • Vincent JE, Melai A, Bonta IL (1974) Comparison of the effects of prostaglandin E1 on platelet aggregation in normal and essential fatty acid deficient rats. Prostaglandins 5: 369–373

    PubMed  Google Scholar 

Download references

Author information

Author notes

  1. H. Kaiya

    Present address: Department of Neurology and Psychiatry, Gifu University School of Medicine, Japan

Authors and Affiliations

  1. Department of Neurology and Psychiatry, Gifu University School of Medicine, Japan

    M. Uematsu, M. Ofuji & K. Takeuchi

  2. Department of Pharmacology, Gifu University School of Medicine, Japan

    M. Nozaki

  3. Department of Chemistry, Faculty of Engineering, Gifu University, Gifu, Japan

    E. Idaka

Authors
  1. H. Kaiya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Uematsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Ofuji
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Nishida
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. Takeuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Nozaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E. Idaka
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaiya, H., Uematsu, M., Ofuji, M. et al. Elevated plasma prostaglandin E2 levels in schizophrenia. J. Neural Transmission 77, 39–46 (1989). https://doi.org/10.1007/BF01255817

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01255817

Keywords

Search

Navigation